ARCH VENTURE FUND VIII, L.P.

Profile

Company Names

ARCH VENTURE FUND VIII, L.P.

Addresses

8725 W. HIGGINS ROAD, SUITE 290, CHICAGO, IL 60631

Phone Numbers

776-380-6600

 

Entity Type:

LIMITED PARTNERSHIP

Industry:

VENTURE CAPITAL FUND

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$400,532,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2014-05-08 
$400,532,000.00 
$400,532,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
N/A 
 
ARCH VENTURE PARTNERS VIII, L.P. 
DIRECTOR
ARCH VENTURE FUND VIII, L.P.
N/A 
 
ARCH VENTURE PARTNERS VIII, LLC 
DIRECTOR
ARCH VENTURE FUND VIII, L.P.
KRISTINA 
 
BUROW 
EXECUTIVE OFFICER
KILIMANJARO ENERGY, INC.   |  LIMERICK BIOPHARMA INC   |  RECEPTOS, INC.   |  TRELYS, INC.   |  CENEXYS, INC.   |  LYCERA CORP   |  ARCH VENTURE FUND VIII, L.P.   |  AGBIOME, LLC   |  METACRINE, INC.   |  SIENNA LABS, INC.   |  SCHOLAR ROCK LLC   |  UNITY BIOTECHNOLOGY, INC.   |  ARCH VENTURE FUND IX, L.P.   |  BORAGEN, INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  GOSSAMER BIO, INC.   |  VIR BIOTECHNOLOGY, INC.   |  BEAM THERAPEUTICS INC.   |  VIVIDION THERAPEUTICS, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  BOUNDLESS BIO, INC.   |  ARCH VENTURE FUND XI, L.P.   |  TREELINE BIOSCIENCES, INC.   |  ARCH VENTURE FUND XII, L.P.   |  NEUMORA THERAPEUTICS, INC.   |  MIRADOR THERAPEUTICS, INC.   |  AUTOBAHN THERAPEUTICS, INC.   |  METSERA, INC.
CLINTON 
W. 
BYBEE 
EXECUTIVE OFFICER
NITRONEX CORP   |  AVESO INC   |  CAMBRIOS TECHNOLOGIES CORP   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.
KEITH 
L. 
CRANDELL 
EXECUTIVE OFFICER
QUANTERIX CORP   |  NEWCO LS15, INC.   |  PERMEON BIOLOGICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  CYTRELLIS BIOSYSTEMS, INC.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
MARK 
 
MCDONNELL 
EXECUTIVE OFFICER
BALYASNY DEDICATED INVESTOR OFFSHORE FUND, LTD.   |  ATLAS FUNDAMENTAL TRADING FUND, LTD   |  UNIVA CORP   |  BAM ZIE FUND, LTD   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
ROBERT 
T. 
NELSEN 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  NEUROGESX INC   |  SAGE THERAPEUTICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  GRAIL, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
PAUL 
 
THURK 
EXECUTIVE OFFICER
ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-08-27
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-05-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#